Medical Hypotheses
Volume 56, Issue 6 , Pages 617-619 , June 2001

Increased superoxide dismutase and Down’s syndrome

Received 23 October 2000 ,Accepted 9 January 2001.

References 

    REFERENCES
  1. Lethem R, Orrell M. Antioxidants and dementia. Lancet. 1997;349:1189–1190
  2. Bras A, Monterio C, Rueff J. Oxidative stress in trisomy 21. A possible role in cataractogenesis. Ophthalmic Paediatr Genet. 1989;10:271–277
  3. De la Torre R, Casado A, López-Fernández E, Carrascosa D, Ramı́rez V, Sáez J. Overexpression of copper-zinc superoxide dismutase in trisomy 21. Experientia. 1996;52:871–873
  4. Avraham KB, Schickler M, Sapoznikov D, Yarom R, Groner Y. Down’s syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell. 1988;54:823–829
  5. Groner Y, Elroy-Stein O, Avraham KB. Cell damage by excess CuZnSOD and Down’s syndrome. Biomed Pharmacother. 1994;48:231–240
  6. White CW, Avraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper–zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest. 1991;87:2162–2168
  7. Nakao N, Frodl EM, Widner H, Carlson E, Eggerding FA, Epstein CJ, et al. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson’s disease. Nature Med. 1995;1:226–231
  8. Jeziorowska A, Jakubowski L, Lach J, Kaluzewski B. Regular trisomy 21 not accompanied by increased copper-zinc superoxide dismutase (SOD1) activity. Clin Genet. 1988;33:11–19
  9. de Grouchy J, Nicole A, Cochet C, Creau-Goldberg N, Sinet PM. Twofold CuZnSOD activity suggesting homozygous submicroscopic duplication of chromosome 21 in the orangutan. Ann Genet. 1988;31:73–74
  10. Paz-Miguel JE, Flores R, Sanchez-Velasco P. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse., a murine model for human Down’s syndrome. J Immunol. 1999;163:5399–5410
  11. Teixeira HD, Schumacher RI, Meneghini R. Lower intracellular hydrogen peroxide levels in cells overexpressing CuZn superoxide dismutase. Proc Nat Acad Sci USA. 1998;95:7872–7875
  12. Klug D, Rabani J, Fridovich I. A direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis. J Biol Chem. 1972;247:4839–4842
  13. Gutteridge JMC. Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels: implications for a wider protective role. FEBS Lett. 1985;185:19–23
  14. Thomas CE, Morehouse LA, Aust SD. Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem. 1985;260:3275–3280
  15. Forabosco A, Sforza C, De Pol A, Vizzotto L, Marzona L, Ferrario VF. Morphometric study of the human neonatal ovary. Anat Rec. 1991;231:201–208
  16. Ciriolo MR, De Martino A, Lafavia E, Rossi L, Carri MT, Rotilio G. Cu. Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J Biol Chem. 2000;275:5065–5072
  17. Tilly JL, Tilly KI. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology. 1995;136:242–252
  18. Troy CM, Shelanski ML. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA. 1994;91:6384–6387
  19. Carri MT, Battistoni A, Polizio F, Desideri A, Rotilio G. Impaired copper binding by the H46R mutant of human Cu., Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett. 1994;356:314–316
  20. Esteban J, Rosen DR, Bowling AC. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet. 1994;3:997–998
  21. Hirano M, Fujii J, Nagai Y. A new variant Cu/Zn superoxide dismutase (Val7—>Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 1994;204:572–577
  22. Sawa A, Oyama F, Cairns NJ, Amano N, Matsushita M. Aberrant expression of bcl-2 gene family in Down’s syndrome brains. Brain Res Mol Brain Res. 1997;48:53–59
  23. Nagy Z. Mechanisms of neuronal death in Down’s syndrome. J Neural Transm Suppl. 1999;57:233–245

PII: S0306-9877(01)91327-1

doi: 10.1054/mehy.2001.1327

Medical Hypotheses
Volume 56, Issue 6 , Pages 617-619 , June 2001

Article Tools